SCOPA 2022: Low vision considerations, treatments, and tools

Video

Jamie Ho, OD, FAAO, FCOVD, shares highlights from her SCOPA 2022 presentation, "Tools and considerations for low vision rehabilitation."

Jamie Ho, OD, FAAO, FCOVD, neuro-rehabilitation optometrist with subspecialties in low vision and brain injury, speaks with Optometry Times® editor Kassi Jackson, sharing highlights from her presentation, "Tools and considerations for low vision rehabilitation," which she presented during this year's South Carolina Optometric Physicians Association's (SCOPA) annual meeting in Hilton Head.

This transcript has been lightly edited for clarity:

Jamie Ho, OD, FAAO, FCOVD:

We're going to talk about low vision, what it is...[and] about the different types of visual impairment.

A lot of times [when] people think low vision, they think about legal blindness, which legal blindness is part of low vision. But there are also many patients who would benefit from low vision services, who actually have much better acuity and fields. And most optometrists will think, "You know, they might not qualify for low vision."

And we're gonna talk about different elements of the low vision exam.

So, different types of ways to assess visual acuity, different types of visual fields involved, besides just threshold field, kinetic fields, what Amslers can tell us clinically, as well as functionally.

We're gonna talk about why it's important to trial frame refract these cases, contrast sensitivity evaluation.

Finally, we're going to talk about the low vision tools such as managing light and glare, simple things like filters, how to position light to optimize reading.

And then we're gonna talk about magnification, traditional magnifiers, handheld magnifiers, some of the caveats that we see with magnification and increasing magnification, spectacle magnifiers hands-free options, specialized devices, such as bioptic telescopes, and rules associated with telescope driving.

And then we're going to talk about cutting edge things like digital wearables, which are probably in the foreseeable future.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.